We are live on ! Find out more
TELO icon

Telomir Pharmaceuticals

39 hedge funds and large institutions have $14.9M invested in Telomir Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

15% more funds holding

Funds holding: 3439 (+5)

13% more capital invested

Capital invested by funds: $13.1M → $14.9M (+$1.77M)

5.09% more ownership

Funds ownership: 6.91%12% (+5.1%)

Holders
39
Holders Change
+5
Holders Change %
+14.71%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
26
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

TELO Hedge Fund Activity: Q4 2024 in Review

39 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Telomir Pharmaceuticals (TELO) for Q4 2024, worth a combined $14.9M — up 13% from $13.1M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TELO positions and 3 closed out — a net gain of 5 holders — while 26 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, adding an estimated $3.25M. The largest seller was LPL Financial, exiting entirely with an estimated $64.2K sold.

  • 39 institutional investors held Telomir Pharmaceuticals (TELO) as of Q4 2024, up from 34 in Q3 2024.
  • Funds reported $14.9M of Telomir Pharmaceuticals stock for Q4 2024, up 13% quarter-over-quarter.
  • 8 funds opened new Telomir Pharmaceuticals positions in Q4 2024 and 3 closed out, a net change of +5 holders.
  • The largest Telomir Pharmaceuticals buyer in Q4 2024 was BlackRock, an estimated $3.25M added.
  • The largest Telomir Pharmaceuticals seller in Q4 2024 was LPL Financial, an estimated $64.2K sold.

Based on aggregated 13F filings for Q4 2024.